Study The Effects Of Abhadi Churna Mashabaladi Kwatha Nasya and Greeva Vasti In Manyastambha

A Comparative Study Of Abhadi Churna Mashabaladi Kwatha Nasya and Greeva Vasti In Manyastambha

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/016902

Enrollment

Registered

2019-01-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

Intervention1: Abhadi Churna.: Abhadi Churna given oraly 5gm B.D. in divided doses with anupan Luke warm water for 15 days. Control Intervention1: Nasya given with Mashabaladi Kwatha and Abhadi Churna

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients between the age group of 18 to 60 years in either sex presenting with clinical features of Cervical Spondylosis (Manyasthambha). 2. Prediagnosed patient of Cervical Spondylosis (Manyasthambha). 3. Patient willing to sign the consent forms.

Exclusion criteria

Exclusion criteria: 1. Cervical fracture and dislocation of cervical vertebrae. 2. Ankylosing spondylitis 3. Cervical rib fracture 4. Cervical compressive myelopathy 5. Patients unfit for Nasya karma. 6. Malignancy 7. Post spinal surgical case 8. Space occupying lesions of brain 9. Psychiatric disorder 10. Uncontrolled Diabetes Mellitus

Design outcomes

Primary

Measure	Time frame
Neck pain intensity reduced 65% assessed by NECK PAIN DISABILITY INDEX QUESTIONNAIRETimepoint: 15 days	—

Secondary

Measure	Time frame
Sleep disturbed reduced 70% assessed by NECK PAIN DISABILITY INDEX QUESTIONNAIRETimepoint: 15 days	—

Countries

India

Contacts

Public ContactPRIYANKA

DSRRAU Jodhpur

drpramodmishra4@gmail.com9001009793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026